Copy number alterations in prostate tumors and disease aggressiveness-Reference-Cited by-同舟云学术

Copy number alterations in prostate tumors and disease aggressiveness

Published:2011-10-02 Issue:1 Volume:51 Page:66-76
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Cheng Iona,Levin Albert M.,Tai Yu Chuan,Plummer Sarah,Chen Gary K.,Neslund-Dudas Christine,Casey Graham,Rybicki Benjamin A.,Witte John S.

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference20 articles.

1. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer;El Gammal;Clin Cancer Res,2010

2. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications;Guan;Clin Cancer Res,2006

3. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists;Huang;Nucleic Acids Res,2009

4. High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer;Ishkanian;Prostate,2009

5. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization;Jenkins;Cancer Res,1997

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatic Tumor Testing in Prostate Cancer: Experience of a Tertiary Care Center Including Pathologist-Driven Reflex Testing of Localized Tumors at Diagnosis;Modern Pathology;2024-06

2. Association between copy number alterations estimated using low-pass whole genome sequencing of formalin-fixed paraffin-embedded prostate tumor tissue and cancer-specific clinical parameters;Scientific Reports;2023-12-17

3. Usefulness of intraoperative ultrasound examination for laparoscopic right-side colon cancer surgery: a propensity score-matched study;Scientific Reports;2023-12-17

4. Genomic Landscape of Meningiomas;Advances in Experimental Medicine and Biology;2023

5. SOX2dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating theFOSL2/IL6axis;2022-06-09